Blog
RSS FeedPosted by Michael Wonder on 26 Aug 2021
PHARMAC seeks feedback on a biosimilar brand of adalimumab being considered for funding
26 August 2021 - PHARMAC is considering awarding Principal Supply to a biosimilar brand of adalimumab (Amgevita) from 1 February ...
Posted by Michael Wonder on 23 Aug 2021
Dulaglutide receives Medsafe approval
23 August 2021 - Dulaglutide will be funded from 1 September 2021. ...
Posted by Michael Wonder on 17 Aug 2021
Information Act shows racism in PHARMAC’s decision-making
17 August 2021 - Paati Māori Co-leader, Debbie Ngarewa-Packer, has received information that blatantly outlines the inequity within PHARMAC and ...
Posted by Michael Wonder on 17 Aug 2021
PHARMAC to fund new cardiovascular medicine with amended Special Authority criteria
17 August 2021 - Pharmac has approved funding for a new medicine with substantial health benefits for around 75,000 New ...
Posted by Michael Wonder on 16 Aug 2021
PHARMAC must explain funding decisions
16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...
Posted by Michael Wonder on 15 Aug 2021
PHARMAC invites entire staff to top secret drug ranking meetings
16 August 2021 - Highly confidential meetings where PHARMAC ranks the funding priority of potentially life-saving medicines are open to ...
Posted by Michael Wonder on 12 Aug 2021
Thousands of south Aucklanders could benefit from Medsafe approving new diabetes drug
12 August 2021 - Medsafe’s approval of a new drug for type 2 diabetes could dramatically change the lives of ...
Posted by Michael Wonder on 05 Aug 2021
Treasury wanted Labour to break all health election promises bar one
5 August 2021 - Treasury told the Government to kick its election promises like funding for PHARMAC, cochlear implants, and ...
Posted by Michael Wonder on 31 Jul 2021
New Zealand Pharmaceutical Schedule - 1 August 2021
1 August 2021 - The August 2021 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Jul 2021
Cancer patients, advocates 'gobsmacked' PHARMAC declining funding application for life-changing drug
29 July 2021 - Ovarian cancer patients and advocates are "utterly gobsmacked" Pharmac has proposed to decline a funding application ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
Posted by Michael Wonder on 19 Jul 2021
PHARMAC ensuring supply of prednisolone to treat children with respiratory conditions
19 July 2021 - PHARMAC is working hard to ensure on-going supply of an important medicine used to treat respiratory conditions ...
Posted by Michael Wonder on 19 Jul 2021
Decision to fund rasagiline
16 July 2021 - PHARMAC is pleased to announce the decision to fund rasagiline (Azilect) a new treatment for people ...
Posted by Michael Wonder on 19 Jul 2021
Decision to widen access to rituximab for people with B-cell acute lymphoblastic leukaemia/lymphoma
9 July 2021 - PHARMAC is widening access to rituximab (Riximyo) to include treatment of people with newly diagnosed B-cell ...
Posted by Michael Wonder on 14 Jul 2021
PM speaks about COVID-19, Fiji and PHARMAC funding
14 July 2021 - Prime Minister Jacinda Ardern spoke to media after a speech at the New Zealand Institute of International ...